Comparison of El-Ganzouri Risk Index and Airway Ultrasonographic Evaluation in Thyroid Surgery

April 15, 2024 updated by: Ankara City Hospital Bilkent

Comparison of El-Ganzouri Risk Index and Airway Ultrasonographic Evaluation In Terms of Predicting Difficult Intubation in Patients Undergoing Thyroid Surgery

The primary purpose of this prospective observational study was to compare these tests used to predict difficult intubation in patients undergoing thyroid surgery. Secondarily; By comparing these tests, we aim to find the test that best predicts difficult intubation and to determine the incidence of difficult intubation in patients who will undergo thyroid surgery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patients' demographic information (age, gender, American Society of Anesthesiologists (ASA) classification, STOP-BANG score(snoring, feeling tired, observed apnea, hypertension, obesity, age, neck circumference and gender), body mass index) and thyroid ultrasonographic measurement will be recorded.

At the preoperative visit, patients will be evaluated for El-Ganzouri Risk Index (EGRI) scores (mouth opening, thyromental distance, mallampati score, neck movement limitation, presence of prognathia, body weight and history of difficult intubation) and for airway ultrasonography (skin-epiglottis distance, skin-hyoid bone distance, skin-vocal cord distance, tongue thickness and tongue volume values).

After this information is recorded, patients will be grouped as those expected difficult intubation and those who are not. After the patients are taken to the operating table and monitored, vascular access will be opened, standard anesthesia induction will be applied to the patients by the room specialist, and laryngoscopy and endotracheal intubation will be performed by the trained (>2 years experienced) anesthesiologist. If Intubation Difficulty Scale (IDS) score will be greater than 5, patient will be considered difficult intubation.

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Çankaya
      • Ankara, Çankaya, Turkey, 06800
        • Ankara Bilkent City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

A total of 120 patients, with ASA scores 1-3, aged between 18-65 years who undergo thyroid surgery will be included.

Description

Inclusion Criteria:

  • Patients with ASA scores 1-3
  • Patients between 18-65 age
  • Patients who undergo thyroid surgery

Exclusion Criteria:

  • Patients who do not accept to participate the research
  • Patients under age 18 and over age 65
  • Pregnant patients
  • Patients who undergo surgery due to emergency medical conditions (such as hematoma, thyroid crisis or myxedema coma)
  • Patients with airway malformations
  • Patients with a high risk of aspiration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Difficult Intubation Expected
Patients whose EGRI scores are equal or greater than 4, or whose skin to epiglottis measurement are greater than 18 mm, skin to hyoid bone measurement are greater than 14 mm, skin to anterior commissure of vocal cords are greater than 13 mm, tongue thickness are greater than 60 mm and tongue volume greater than 100 cm3.
EGRI scores and airway ultrasonographic values will be recorded in patients who undergo thyroid surgery.
Difficult Intubation Not Expected
Patients who do not meet the criteria just mentioned
EGRI scores and airway ultrasonographic values will be recorded in patients who undergo thyroid surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare EGRI and airway ultrasonographic parameters
Time Frame: Up to 6 months, until the end of the study
Compare EGRI and airway ultrasonography for predicting difficult intubation in patients who undergoing thyroid surgery
Up to 6 months, until the end of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Find which is the best test predicts difficult intubation
Time Frame: Up to 6 months, until the end of the study
by comparing these tests to decide which test is the best predictor for difficult intubation in thyroid surgery
Up to 6 months, until the end of the study
Finding the incidence of difficult intubation in thyroid surgery
Time Frame: Up to 6 months, until the end of the study
Determine the incidence of difficult intubation in thyroid surgery
Up to 6 months, until the end of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şeref Çelik, Ankara Bilkent City Hospital, Algology Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Actual)

October 31, 2023

Study Completion (Actual)

January 28, 2024

Study Registration Dates

First Submitted

April 4, 2024

First Submitted That Met QC Criteria

April 15, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 15, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult Intubation

Clinical Trials on Thyroid Surgery

Subscribe